Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218042 · ClinicalTrials.gov registry record · NA
Study of Procedural Efficiency in EBUS With Dual Versus Single NEEDLEs: Evaluating the Value of a Second Needle in EBUS as it Pertains to Economic and Environmental Impact
A NA study of Mediastinal and Hilar Lymphadenopathy, sponsored by Christopher Kapp.
- Active
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 3
- Study locations
NCT07218042 is a NA study of Mediastinal and Hilar Lymphadenopathy that is active but no longer recruiting, run by Christopher Kapp. The registered enrollment target is 126 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT07218042, a NA study of Mediastinal and Hilar Lymphadenopathy, is active but no longer recruiting, sponsored by Christopher Kapp.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 3
- Study locations
Study Summary
Currently, the EBUS bronchoscopy procedure uses either one or two needles to perform the biopsy of the lymph node based on physician preference. We want to determine the optimal number of needles to use for future EBUS bronchoscopy procedures like the one you are scheduled to have for your care and investigate the economic and environmental impact and time involved in using one versus two needles.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles.
Study Locations (3)
California
- University of California, Davis - Sacramento
Illinois
- Northwestern University - Chicago
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07218042
The ClinicalTrials.gov registry entry for NCT07218042 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christopher Kapp, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mediastinal and Hilar Lymphadenopathy appearing as the primary indexed condition, and to 1 intervention - of which We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles. is the first listed.
NCT07218042 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07218042 about?
NCT07218042 is a clinical study titled "Study of Procedural Efficiency in EBUS With Dual Versus Single NEEDLEs: Evaluating the Value of a Second Needle in EBUS as it Pertains to Economic and Environmental Impact". Currently, the EBUS bronchoscopy procedure uses either one or two needles to perform the biopsy of the lymph node based on physician preference. We want to determine the optimal number of needles to use for future EBUS bronchoscopy procedures like the one you are scheduled to have for your care and ...
What is the current status of trial NCT07218042?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2024-02-02. Estimated completion is 2025-12-31.
What conditions does trial NCT07218042 study?
This clinical trial studies the following conditions: Mediastinal and Hilar Lymphadenopathy.
What interventions are being tested in trial NCT07218042?
The interventions under investigation include: We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07218042?
This trial is sponsored by Christopher Kapp, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07218042 being conducted?
This trial has 3 study locations across California, Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.